RE:Prowse and Conz Hi MM. Perhaps the overallotment will cover the costs of issue. So they may have Cdn $5 million in proceeds. Given the 90 patient interim milestone (71 done right now) should be within the next 4 months the redacted payment from Baxter could be received. We aren't privy to that amount but given the current amount of raise could we surmise it'll be sufficient to top them off for the next year?
With Baxter's KidneyCo ready for launch in 2024 would Baxter entertain taking over the Tigris trial if they're happy with the results of the 90 person "exceeding expectations" details? It would be some market "sizzle" for their new KidneyCo company launch. It would be like buying a race horse in the final stretch of the Kentucky Derby that is leading by so many lengths that the win is certain. Incentive is to appear in the Winners Circle at race end with all the fanfare that provides.